Language

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.   

Select Language
Careers
Main Number: 571.350.8400
Clinical Trials: 703.636.1473
New Patient
Refer a Patient
Virginia Cancer Specialists logo

Virginia Cancer Specialists Clinical Research Leader Receives SCRI Site Partnership Excellence Award

Sullivan Award

FAIRFAX, Va., August 4, 2026 /PRNewswire/ — Virginia Cancer Specialists, a premier oncology practice in Northern Virginia and a leader in community-based cancer research, is proud to announce that Marcy Sullivan RN, BSN, OCN, Director of Research Operations at Virginia Cancer Specialists Research Institute, has been recognized with the Sarah Cannon Research Institute (SCRI) Site Partnership […]

Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role

Macro shot of a 3D visualization of DNA damage in cancer cells, focusing on molecular structures

FOR IMMEDIATE RELEASE Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role Fairfax, VA — May 12, 2026 — Virginia Cancer Specialists announced today its participation as a leading clinical trial site in a landmark study evaluating daraxonrasib, a first-in-class targeted oral therapy for patients […]

Landmark Non-Small Cell Lung Cancer Study – Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

Lung cancer on blue background, 3D illustration

Virginia Cancer Specialists Research Institute – Landmark “Non-Small Cell Lung Cancer Study” – Alexander I. Spira, MD, PhD, FACP  Planned interim overall survival analysis showed a trend favoring the combination of RYBREVANT® and lazertinib compared to osimertinib* First pivotal study to show a clinically meaningful benefit in a chemotherapy-free regimen versus osimertinib  – See the […]